NO20052534L - Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer - Google Patents

Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer

Info

Publication number
NO20052534L
NO20052534L NO20052534A NO20052534A NO20052534L NO 20052534 L NO20052534 L NO 20052534L NO 20052534 A NO20052534 A NO 20052534A NO 20052534 A NO20052534 A NO 20052534A NO 20052534 L NO20052534 L NO 20052534L
Authority
NO
Norway
Prior art keywords
antibacterial agents
isocazoline
oxazolidinone
derivatives
het
Prior art date
Application number
NO20052534A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052534D0 (no
Inventor
Michael Barry Gravestock
Neil James Hales
Sheila Irene Hauck
Daniel Robert Carcanague
Thomas Peter Weber
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0227702A external-priority patent/GB0227702D0/en
Priority claimed from GB0304725A external-priority patent/GB0304725D0/en
Priority claimed from GB0318608A external-priority patent/GB0318608D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20052534D0 publication Critical patent/NO20052534D0/no
Publication of NO20052534L publication Critical patent/NO20052534L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
NO20052534A 2002-11-28 2005-05-26 Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer NO20052534L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0227702A GB0227702D0 (en) 2002-11-28 2002-11-28 Chemical compounds
GB0304725A GB0304725D0 (en) 2003-03-01 2003-03-01 Chemical compounds
GB0318608A GB0318608D0 (en) 2003-08-08 2003-08-08 Chemical compounds
PCT/GB2003/005087 WO2004048392A1 (en) 2002-11-28 2003-11-24 Oxazolidinone and / or isoxazoline derivatives as antibacterial agents

Publications (2)

Publication Number Publication Date
NO20052534D0 NO20052534D0 (no) 2005-05-26
NO20052534L true NO20052534L (no) 2005-08-22

Family

ID=32397650

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052534A NO20052534L (no) 2002-11-28 2005-05-26 Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer

Country Status (15)

Country Link
US (1) US20060116400A1 (ko)
EP (1) EP1567532A1 (ko)
JP (1) JP2006508192A (ko)
KR (1) KR20050085193A (ko)
AU (1) AU2003302404B2 (ko)
BR (1) BR0316688A (ko)
CA (1) CA2507468A1 (ko)
HK (1) HK1079794A1 (ko)
IL (1) IL168747A0 (ko)
MX (1) MXPA05005651A (ko)
NO (1) NO20052534L (ko)
NZ (1) NZ540147A (ko)
SA (1) SA04250088A (ko)
TW (1) TW200533666A (ko)
WO (1) WO2004048392A1 (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60205030T2 (de) * 2001-09-11 2006-04-20 Astrazeneca Ab Oxazolidinon- und/oder isoxazolinderivate als antibakterielle mittel
BR0308018A (pt) 2002-02-28 2005-01-04 Astrazeneca Ab Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo
MXPA04008312A (es) 2002-02-28 2004-11-26 Astrazeneca Ab Derivados de 3-cilil-5-(anillo de 5 miembros que contienen nitrogeno)-metil-oxazolidinona y sus uso como agentes antibacterianos.
GB0227701D0 (en) * 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds
KR20050084010A (ko) 2002-11-28 2005-08-26 아스트라제네카 아베 항균제로서의 옥사졸리디논
TW200500360A (en) * 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
TWI454465B (zh) 2003-06-03 2014-10-01 Melinta Therapeutics Inc 聯芳基雜環化合物及製法及其用途
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
EP1660465B1 (en) * 2003-07-29 2014-12-17 Melinta Therapeutics, Inc. Process for the synthesis of biaryl oxazolidinones
JP4777246B2 (ja) * 2003-07-29 2011-09-21 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ビアリールオキサゾリジノンの合成方法
US7129259B2 (en) 2003-12-17 2006-10-31 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
AU2005247671A1 (en) * 2004-05-25 2005-12-08 Astrazeneca Ab 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as MAO inhibitors for the treatment of bacterial infections
US20080064689A1 (en) * 2004-05-25 2008-03-13 Astrazeneca Ab 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
US8399660B2 (en) 2005-06-08 2013-03-19 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
ES2748505T3 (es) * 2008-10-10 2020-03-17 Merck Sharp & Dohme Métodos para la preparación de oxazolidinonas y composiciones que las contienen
CU24089B1 (es) 2009-02-03 2015-04-29 Trius Therapeutics Forma cristalina del fosfato de dihidrógeno r)-3-(4-(2-(2-metiltretazol-5-il)-3-fluorofenil)-5-hidroximetil oxazolidin-2-ona
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
US9000200B2 (en) * 2011-12-19 2015-04-07 Saudi Basic Industries Corporation Process for the preparation of metallocene complexes
JP6454548B2 (ja) * 2011-12-19 2019-01-16 サウディ ベーシック インダストリーズ コーポレイション メタロセン錯体を調製するプロセス
CN113149924B (zh) * 2021-03-29 2023-11-03 苏州大学 一种异噁唑啉的简单制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
CA2411859A1 (en) * 2000-06-05 2001-12-13 Jae-Gul Lee Novel oxazolidinone derivatives and a process for the preparation thereof
DE60205030T2 (de) * 2001-09-11 2006-04-20 Astrazeneca Ab Oxazolidinon- und/oder isoxazolinderivate als antibakterielle mittel
GB0227701D0 (en) * 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
BR0316688A (pt) 2005-10-18
EP1567532A1 (en) 2005-08-31
AU2003302404B2 (en) 2008-06-19
NZ540147A (en) 2008-03-28
US20060116400A1 (en) 2006-06-01
SA04250088A (ar) 2005-12-03
IL168747A0 (en) 2009-02-11
KR20050085193A (ko) 2005-08-29
HK1079794A1 (zh) 2006-04-13
AU2003302404A1 (en) 2004-06-18
NO20052534D0 (no) 2005-05-26
CA2507468A1 (en) 2004-06-10
JP2006508192A (ja) 2006-03-09
WO2004048392A1 (en) 2004-06-10
MXPA05005651A (es) 2005-07-27
TW200533666A (en) 2005-10-16

Similar Documents

Publication Publication Date Title
NO20052534L (no) Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer
NO20053133L (no) Kjemiske forbindelser.
MXPA03010877A (es) Derivados de 2-anilin-pirimida como inhibidores de cinasa dependientes de ciclina.
WO2006034446A3 (en) Pyridine derivatives for inhibiting human stearoyl-coa-desaturase
NO20070032L (no) Hetroarylbenzamid-derivater for anvendelse som GLK-aktivatorer ved behandling av diabetes
WO2006034341A3 (en) Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
DE60317326D1 (de) Phenylalkansäure- und phenyloxyalkansäure-derivate als hppar aktivatore
WO2008114819A1 (ja) 新規アデニン化合物
TW200640900A (en) 1-(2h)-isoquinolone derivative
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
WO2006067392A3 (en) Indole derivatives for the treatment of tuberculosis
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
NO20090346L (no) Pyrazolderivater som inhibitorer av cytokrom P450
MXPA05012247A (es) Derivados de bencimidazol nuevos.
TW200503998A (en) Phenyl compounds
GEP20104875B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
UA95223C2 (ru) Производные пиридопиримидина, их получение, их применение в терапии
MX2007007480A (es) Derivados de cromano y su uso como ligandos del receptor 5-ht.
MY186650A (en) Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
WO2006110884A3 (en) 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
JO2413B1 (en) Benzoxazine derivatives and their use
WO2000068198A3 (en) Heterosubstituted pyridine derivatives as pde 4 inhibitors
AU2003237955A8 (en) Phenyloxyalkanonic acid derivatives as hppar activators
DE60327998D1 (de) Pyrimidine verbindungen
NO20043951L (no) 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application